Novel Glaucoma Medications: From Clinical Trials to Clinical Experience episode artwork

EPISODE · Apr 27, 2021 · 9 MIN

Novel Glaucoma Medications: From Clinical Trials to Clinical Experience

from GT: The Podcast · host Glaucoma Today

Vladislav P. Bekerman, MD, MBA, an ophthalmology resident at Rutgers New Jersey Medical School, offers insight into the use of new treatments as additive therapies for IOP reduction, as featured in an article by Bekerman and Albert S. Khouri, MD, in the January/February 2021 issue of Glaucoma Today.

Vladislav P. Bekerman, MD, MBA, an ophthalmology resident at Rutgers New Jersey Medical School, offers insight into the use of new treatments as additive therapies for IOP reduction, as featured in an article by Bekerman and Albert S. Khouri, MD, in the January/February 2021 issue of Glaucoma Today.

NOW PLAYING

Novel Glaucoma Medications: From Clinical Trials to Clinical Experience

0:00 9:14

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of GT: The Podcast?

This episode is 9 minutes long.

When was this GT: The Podcast episode published?

This episode was published on April 27, 2021.

What is this episode about?

Vladislav P. Bekerman, MD, MBA, an ophthalmology resident at Rutgers New Jersey Medical School, offers insight into the use of new treatments as additive therapies for IOP reduction, as featured in an article by Bekerman and Albert S. Khouri, MD, in...

Can I download this GT: The Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!